Trial Profile
A Single Arm, Open-label, Multicenter, Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer Patients
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 05 May 2021
Price :
$35
*
At a glance
- Drugs Chlorogenic acid (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer; Small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- Sponsors Sichuan J.Z. Bio-chemical Science and Technology Development Co
- 28 Nov 2018 New trial record